Investorideas.com newswire, breaking news for marijuana, cannabis and hemp stocks

Tuesday, 23 February 2021

Breaking #CBD/ #Water #Stock news - American Premium Water Corp. (OTC: $HIPH) Announces Joint Venture With Cali Bear to Sell CBD Infused Waters, Edibles, and Topicals; @AmericanPremium

Breaking #CBD/ #Water #Stock news - American Premium Water Corp. (OTC: $HIPH) Announces Joint Venture With Cali Bear to Sell CBD Infused Waters, Edibles, and Topicals; @AmericanPremium

 

The Company Will Produce Products Labeled with the Lifestyle Brand for Distribution in the US and Internationally as Part of the Joint Venture

 


PLAYA VISTA, CA –  February 23, 2021 - Breaking  CBD/water stock news from Investorideas.com Newswire- American Premium Water Corporation (OTC: HIPH) (the “Company”) announces that it has entered into an agreement to form a Joint-Venture with Cali Bear (www.calibear.life ), a lifestyle CBD brand to produce CBD infused water, edibles, and topicals under the Cali Bear brand, with full participation of the Team Cali Bear influencers. The Joint Venture will cover domestic and international retail and e-commerce channels. Products are expected to be available for purchase online by April 20th, 2021.

 

Read this news, featuring HIPH in full at https://www.investorideas.com/news/2021/cannabis/02231HIPH-Cali-Bear-Sell-CBD.asp

 

Ryan Fishoff, CEO of American Premium Water, commented, “I am very excited to announce the signing of a Joint Venture agreement with Cali Bear. This is a tremendous opportunity to partner with an emerging CBD brand that sets the standard for ‘performance lifestyle’. The brand has a great aesthetic that will translate well in the marketplace. Cali Bear embodies the sport, beach, and surf culture, an embodiment of the California lifestyle which is synonymous with fun, excitement, and high level performance. The CBD products that we are manufacturing combined with our nano technology, delivering the best possible user experience for the consumer, fits well within the ethos of the brand. I believe our collective efforts will take the Company to new heights, as this Joint Venture provides the Company with a significant revenue stream from the various products that will be sold. This partnership will allow the Company to expedite our distribution strategy, as there are a number of outlets that have already shown interest in these products, both domestically and internationally. We anticipate the launch date for these products to be around April 20th, 2021. The Joint Venture also allows for the Company to produce branded smokable CBD products and THC-infused beverages, something both parties will explore later this year.”

 

As part of the Joint Venture, the Company will be responsible for the production, manufacture, and distribution of the products sold under the Joint Venture. This includes management and fulfillment of e-commerce orders. Cali Bear, founded in 2018, has assembled a team of influencers and brand ambassadors that will provide the Company high quality engagement and content to promote a robust direct-to-consumer e-commerce strategy. Cali Bear’s team of ambassadors include gold medalist and four-time Brazillian national team Olympian Ricardo Santos, 2021 Team USA Olympian Trevor Crabb, 18-year AVP Beach Volleyball veteran Ty Loomis, AVP Tour professional Miles Evans, Puerto Rican national team member Roberto “Rafu” Rodriguez, and Polish national team member Piotr Marciniak.

 

Christopher Shipps, Founder of Cali Bear, commented, “Cali Bear is dedicated to sourcing the best ingredients and innovative CBD technologies. A Joint Venture with American Premium Water (APW) will streamline Cali Bear, while providing our customers with consistent, high quality, natural, and organic products. I foresee that together, this partnership can achieve rapid sales growth within the US and internationally. Our distribution program will leverage our multi-national influencer team and quickly propel the brand. Cali Bear is very excited for our Joint Venture with APW, the future looks bright together."

 

About American Premium Water Corp.

American Premium Water (OTC: HIPH) is a diversified luxury consumer products company focused on businesses in the health and beauty and biotech sectors. The company is focused on harnessing the powers of Nano technologies paired without cannabidiol (CBD) to treat health disorders and enhance quality of life. The company’s portfolio includes the LALPINA Hydro and LALPINA CBD brands (www.lalpinahydrocbd.com ), Gents (www.gentsco.com), Vanexxe (www.vanexxe.com) plant + body essentials (www.plantbodyessentials.com).

 

Safe Harbor Notice

Certain statements contained herein are “forward-looking statements” (as defined in the Private Securities Litigation Reform Act of 1995). American Premium Water Corporation cautions that statements made in this news release constitute forward-looking statements and makes no guarantee of future performance. Forward-looking statements are based on estimates and opinions of management at the time statements are made. These statements may address issues that involve significant risks, uncertainties, estimates and assumptions made by management. Actual results could differ materially from current projections or implied results. American Premium Water Corporation undertakes no obligation to revise these statements following the date of this news release. Additional details of the Company's business can be found in its public disclosures as a reporting issuer under the Securities Exchange Act of 1934 filed with the Securities and Exchange Commission's ("SEC") EDGAR database.

 

This press release is issued on behalf of the Board of Directors of American Premium Water Corporation.

 

Investor Relations

888-983-0054

info@americanpremiumwater.com

 

Paid News -Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Disclosure : this news release featuring HIPH is a paid for news release on Investorideas.com  More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com

Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

 

About Investorideas.com and http://www.renewableenergystocks.com/

https://www.investorideas.com/About/

 

Sign up for free stock news alerts at Investorideas.com

https://www.investorideas.com/Resources/Newsletter.asp

 

Investors can trade these stocks and other ideas on our site using our list of top stock trading apps including Robinhood, Acorn, Stash and others. 



Get more Cannabis Stock Investor Ideas - news, articles, podcasts and stock directories

 



Water-Stocks.com: investing ideas in water stocks

Like Water Stocks? View our Water Stocks Directory  Get News Alerts on Water Stocks

 

Sector snapshot - Future of #FunctionalMushrooms and #PsychedelicMushrooms (OTC: $LRSV) (OTCQB: $SHRMF) (OTCQB: $MMEDF) (OTC: $RVVTF); @res_pet @mindmedco @Revive_RVV

 

Sector snapshot - Future of #FunctionalMushrooms and #PsychedelicMushrooms (OTC: $LRSV) (OTCQB: $SHRMF) (OTCQB: $MMEDF) (OTC: $RVVTF); @res_pet  @mindmedco @Revive_RVV

 

 


Point Roberts WA, Delta BC – February 23, 2021 - Investorideas.com, a leading investor news resource on health and wellness stocks releases a sector snapshot looking at a health revolution taking place with the growing functional mushroom and psychedelic mushroom markets, featuring  Link Reservations Inc. (OTC PINK: LRSV).

 

Read this news, featuring LRSV in full at https://www.investorideas.com/news/2021/lohas/02231LRSV-SHRMF-MMEDF-RVVTF.asp

 

According to Data Bridge Market Research, “The functional mushroom market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses that the market is growing with the CAGR of 7.22% in the forecast period of 2021 to 2028 and is expected to reach USD 555.94 billion by 2028. The increasing use of the ingredient in the healthcare sector is escalating the growth of functional mushroom market.”



New to the functional mushroom market, Link Reservations Inc. (OTC PINK: LRSV), a provider of wellness and cannabidiol (CBD) products for both humans and pets just announced the expansion of its DailyLifeCBD product line to include a suite of functional mushroom-infused products. The Company, having recently acquired DailyLifeCBD to enter the health and wellness sector, is looking to expand its range of complementary well-being products with an emphasis on natural and organic ingredients.

Due to the Covid-19 global pandemic, consumers are increasingly searching for ways to boost their immune system, seen by the market growth of alternative and complementary products. Functional (or medicinal) mushrooms possess beneficial properties such as antibacterial, anti-inflammatory and immunomodulating effects - meaning they help keep the immune system in balance. Functional mushrooms are specific varieties, such as Shiitake, Reishi, Maitake and Chaga, amongst others.

Having recently expanded into the health and wellness sector through its acquisition of DailyLifeCBD - a website selling CBD products for people - LRSV is now pursuing the development and commercialization of rapid onset treatments capable of improving health outcomes such as depression and post-traumatic stress disorder (PTSD), as well as substance and alcohol use disorders.

"We are very excited and much looking forward to the opportunity for growth brought by the sale and distribution of our new premium, functional mushroom-infused suite of products. As a Company, our focus continues to be on providing high quality, natural products that can benefit the health and wellbeing of consumers," commented Rene Lauritsen, CEO at Link Reservations Inc. "At the same time we aim to continue growing our revenue and increasing shareholder value through acquisitions and product range expansion. The LRSV team is confident of the potential that this new product suite has in enhancing the health and wellness of millions of consumers," he added.

The Company plans to initiate activities through DailyLifeCBD with a range of non-edible lifestyle products for people and expand on the range as the site and demand grows. LRSV is considering the possibility of a subsidiary solely focused on its mushroom-infused products.

"Our expectation, based on discussions with our manufacturer is to have these new products available for sale in the coming weeks - we are very excited by this. We will keep shareholders and the investment community updated through press releases as developments arise," said Lauritsen.

Finally, if and when Federal and jurisdiction laws allow, Link Reservations Inc. (OTC PINK: LRSV) is setting its eyes on a greater prize, with a potential suite of psychedelic mushroom-infused products to follow the functional mushroom products.

The Psychedelic mushroom stock sector has grown enough that an ETF has been created around it, currently trading on the NEO Exchange, the HORIZONS PSYCHEDELIC STOCK INDEX ETF is an indication of future growth opportunities.

 

TOP 10 HOLDINGS AS AT FEBRUARY 12, 2021:

Security Name                                                 Weight

SEELOS THERAPEUTICS INC                                       12.51%

NUMINUS WELLNESS INC                                 10.09%

FIELD TRIP HEALTH LTD                                   9.99%

MIND MEDICINE (MINDMED) INC SUB VTG        9.49%

COMPASS PATHWAYS PLC ADR                         8.71%

RED LIGHT HOLLAND CORP                                        6.9%

GREENBROOK TMS INC NEW                            6.82%

CYBIN INC                                                       6.24%

REVIVE THERAPEUTICS LTD.                            5.14%

JOHNSON & JOHNSON                                      4%

 

Last week, Revive Therapeutics Ltd. (CSE: RVV) ( RVVTF), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders and one of the holdings in the ETF announced that, further to its press release dated December 21, 2020, it has entered into an asset purchase agreement with Newscope Capital Corporation (CSE: PHRM) (OTCQB: PHRRF) to acquire the full rights to PharmaTher Inc.’s  intellectual property (the “Acquired Assets”) pertaining to psilocybin (the “Acquisition”). PharmaTher, a wholly-owned subsidiary of Newscope, is a specialty life sciences company focused on the research and development of psychedelic pharmaceuticals.

 

“With this acquisition, we have solidified our foundation in having a leading psychedelics pharmaceutical platform with a focus on proprietary psilocybin-based therapeutics that includes the development of an oral thin film product in collaboration with the University of Wisconsin-Madison, a novel biosynthetic version of psilocybin based on a natural biosynthesis enzymatic platform developed by Dr. Gavin Williams, Professor and Researcher at North Carolina State University, a clinical study with the University of Wisconsin evaluating psilocybin in the treatment of methamphetamine use disorder, and PharmaTher’s psilocybin research initiatives and intellectual property in stroke, traumatic brain injury, cancer and drug combinations,” said Michael Frank, CEO of Revive. “We are now in a position to advance our psilocybin program for future clinical development in various unmet clinical needs in mental health, cancer and neurological disorders.”

 

Looking at how psychedelic mushrooms may be playing a role in mental health, in late January Champignon Brands Inc. (OTCQB: SHRMF) Chairman and CEO, Roger McIntyre announced the opening of a new Canadian Rapid Treatment Center of Excellence (CRTCE) clinic in Ottawa, Ontario. This third clinic joins the Mississauga and Toronto clinics (CRTCE Clinics) in addressing the unmet need of depression and suicide through novel ketamine therapy treatment.

 

“Over twenty clinical trials have demonstrated that ketamine and esketamine have rapid and robust antidepressant effects in patients that have failed to respond to conventional antidepressants. During the COVID-19 pandemic, the need for effective treatment has become exponentially critical," said Dr. Joshua Rosenblat, Medical Director, CRTCE. "Ketamine treatment for depression is very difficult to access in Canada. This third clinic should allow more people to access treatment."

 

MindMed (NEO:MMED) (OTCQB:MMEDF), a psychedelic medicine biotech company that discovers, develops and deploys psychedelic inspired medicines and therapies to address addiction and mental illness announced just recently that it will acquire HealthMode, a digital medicine and therapeutics startup that uses Artificial Intelligence (AI)-enabled digital measurement to increase the precision and speed of clinical research and patient monitoring.

 

MindMed Co-Founder and CEO, J.R. Rahn said, "Our mission is to make MindMed as much a digital medicine company as a drug development company. With the addition of Dan and Bradford's team of engineers and product experts, our digital medicine division, Albert, is now the Special Ops of digital medicine, applying machine learning to drug development and patient care. The future of modern mental healthcare and psychedelic medicine ultimately will rely on improving infrequent, self-reported and observed measures for mental health to a paradigm where the continual digital measurement of our mind and body is as vital as the drug treatment itself. In effect, we see a future mental health treatment paradigm where potential drug products such as our LSD experiential therapy might be prescribed right alongside software application programming interfaces (APIs) to prepare the patient for treatment and optimally monitor the after-care of one's anxiety disorder."

 

What does the future hold for functional and psychedelic mushrooms for consumers and investors?  According to a recent article,”After successfully traveling through the niche wellness-to-mainstream pipeline, mushrooms are set to get more “magical” with the prospect of wider legalization of psychedelics.”

 

Investors can research the sector with a list of health and wellness stocks  at Investorideas.com

 

Investors can research psychedelic stocks at https://www.investorideas.com/Marijuana-Stocks/Stocks_List.asp

 

About Investorideas.com - News that Inspires Big Investing Ideas Investorideas.com is a recognized news source publishing third party news, research and original financial content. Learn about investing in stocks and sector trends with our news alerts, articles, podcasts and videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable energy and more. Investor Idea’s original branded content includes the following podcasts and columns : Crypto Corner , Play by Play sports and stock news column, Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast and column,  Cleantech and Climate Change , Exploring Mining  the AI Eye .

 

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions. Disclosure: this news article featuring LRSV is a paid for news release on Investorideas.com – third party: Learn more about  the cost of publishing your news release and our article creation https://www.investorideas.com/News-Upload/ and tickertagstocknews.com More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

 

Contact Investorideas.com

800-665-0411


Friday, 19 February 2021

Investorideas.com - Cannabis Stock News: Emerald Health Therapeutics (TSXV: EMH) (OTCQX: EMHTF) to Close Greater Vancouver Production Facility

Investorideas.com - Cannabis Stock News: Emerald Health Therapeutics (TSXV: EMH) (OTCQX: EMHTF) to Close Greater Vancouver Production Facility

Investor Ideas #Potcasts 533, #Cannabis News and #Stocks on the Move; Interview with Jason Malcolm, Co-Lead of Arcview Management Consulting

 


Investor Ideas #Potcasts 533, #Cannabis News and #Stocks on the Move; Interview with Jason Malcolm, Co-Lead of Arcview Management Consulting

 

Delta, Kelowna, BC, February 19th, 2021 (Investorideas.com Newswire) www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its potcast site, www.potcasts.ca  release today’s podcast edition of  cannabis news and stocks to watch plus insight from thought leaders and experts.

 

Listen to the podcast:

https://www.investorideas.com/Audio/Podcasts/2021/021921-StocksToWatch.mp3

 

Read this in full at https://www.investorideas.com/news/2021/cannabis-potcasts/02191Interview-Jason-Malcolm-Archview.asp

 

Hear Investor ideas cannabis potcast on iTunes  

 

Hear the investor ideas potcast on Spotify

 

Today’s podcast overview/transcript:

 

Good afternoon and welcome to another episode of Investorideas.com "Potcast" featuring cannabis news, stocks to watch as well as insights from thought leaders and experts.

 

In today’s podcast Investorideas interviews Jason Malcolm, Co-Lead of the Arcview Management Consulting Team, where we discussed the recent expectations surrounding legalization in the US, current cannabis market trends as well as Jason’s role with Arcview in the Tri-State area.

 

The Arcview Group announced Jason’s addition to the team back in January. Jason co-leads as Principal alongside industry veteran, David Abernathy to help develop and implement strategies for international organizations across the private, public, and social sectors.

 

In this new role, Jason has helped clients in the cannabis, CBD, industrial hemp, or CPG industries transform their business to ensure market competitiveness. Jason and the Arcview team not only reimagine go-to market strategies for clients, but also determine archetypal patterns, conduct case studies, provide market insights, and personalize additional services for businesses. Jason will also guide new cannabis business owners as they navigate new industry regulations in the Northeast and across the country.

"Cannabis hype has accelerated over the last few years with the conversion of medical-only states to fully legal states and we see that momentum accelerating. Living in New Jersey gives me a unique perspective on what will be an epicenter for the industry's success," states Jason Malcolm, Principal at Arcview Management Consulting. "With more legalization around the globe, the flood of investments from existing companies, such as those in the tobacco and alcohol companies, has newfound opportunities for expansion."

 

"The two new pillars, Federal Readiness and ESG, will open the market to new players and we are thrilled to welcome crossover executives like Jason to drive this business forward," comments Kim Kovacs, CEO of The Arcview Group. "Some of the most interesting sets of clients we aim to assist are those not yet in cannabis, such as trailblazers from CPG, Alcohol, and AgTech. Most are looking to a trusted leader in the space to align with."

 

Having been active in financial services for over 15 years at firms, such as Bearing Point and EY, Jason has worked within all levels of consulting firms.

 

When asked about whether the Archview Consulting Team will be focussing on servicing more developed cannabis companies or startups Mr. Malcolm commented, “It’s both. We focus a lot on some of the start ups who are either seeking capital or need help to get them  to market in specific markets of interest. Then we also help existing cannabis companies to grow and scale their business. We offer a slew of services and to help existing cannabis companies as well as start ups will always be our bread and butter.”

 

When asked about some of the current considerations companies should be evaluating when looking at the potential for US legalization or rescheduling over the next few years Malcolm continued, “So we just launched a federal readiness campaign, which is one of our four pillars of Archview Management Consulting, that focussed specifically on what happens to specific companies when the Fed flips a switch and cannabis is legal nationwide. In some cases, some companies might be very well positioned from an infrastructure or business model perspective for that federal legalization change, while some other companies might not be. So we want to be able to have those kinds of conversations and really understand what they do today, how well they do it and what they’ll look like tomorrow if the Fed were to legalize cannabis nationwide. That’s really going to be us putting together a SWOT Analysis of what they look like currently and how they need to look tomorrow, and if they’re not going to be in a position that’s of advantage to them, what are some of their options post legalization?”

 

Mr. Malcolm went on to discuss some of the main benefits surrounding legal expansion in the Tri-State area, how he anticipates the roll out of congressional changes such as the MORE, SAFE and STATES Acts as well as Archview Management Consulting’s expectations for 2021.

 

To find out more about Archview Consulting visit their website here.

 

Investor ideas reminds all listeners to read our disclaimers and disclosures on the Investorideas.com website and that this podcast is not an endorsement to buy products or services or securities. Investors are reminded all investment involves risk and possible loss of investment.

 

Learn more about our cannabis podcasts at https://www.investorideas.com/Audio/Potcasts.asp

Or www.potcasts.ca

 

 

To hear more Investorideas.com podcasts visit: https://www.investorideas.com/Audio/.

Investorideas.com podcasts are also available on iTunes,  Spotify, Google Play Music, Stitcher, Spreaker,   YouTube via Spreaker,  iHeartradio and Tunein.

 

Potcasts is now a certified word mark Trademark on the blockchain through Cognate, Inc. CM Certification-Registration Number: 10468217708

 

About Investorideas.com - News that Inspires Big Investing Ideas

Investorideas.com is a recognized news source publishing third party news, research and original financial content. Learn about investing in stocks and sector trends with our news alerts, articles, podcasts and videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable energy and more. Investor Idea’s original branded content includes the following podcasts and columns : Crypto Corner , Play by Play sports and stock news column, Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast and column,  Cleantech and Climate Change , Exploring Mining  the AI Eye .

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com

Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

 

Investor Ideas does not condone the use of cannabis except where permissible by law. Our site does not possess, distribute, or sell cannabis products.

 

Learn more about sponsoring this podcast or be a guest and our other branded content opportunities at Investorideas.com

 

Follow us on Twitter https://twitter.com/Investorideas

Follow us on Facebook https://www.facebook.com/Investorideas

Follow us on YouTube https://www.youtube.com/c/Investorideas

Download our Mobile App for iPhone and Android 

Join our Investor Club https://www.investorideas.com/membership/

 

Contact Investorideas.com

800 665 0411

 

 


  Get more Cannabis Stock Investor Ideas – news, articles, podcasts and stock directory

Cannabis Deal Tracker: Investment and M&A Activity in the Cannabis Industry September 13th - September 17th, 2021

Cannabis Deal Tracker: Investment and M&A Activity in the Cannabis Industry September 13th - September 17th, 2021